InsiderTrades

Form 4 for PCVX Vaxcyte, Inc.

Accepted 2024-09-05 00:00:00 ET · period of report 2024-09-03 · accession 0001649094-24-000063 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-09-05 2024-09-03 PCVX Cowan Elvia SVP, Fin M - OptEx $25.92 +5,000 17.7K +39% +$129.6K
D 2024-09-05 2024-09-03 PCVX Cowan Elvia SVP, Fin S - Sale+OE $107.67 -5,000 12.7K -28% -$538.4K
D 2024-09-05 2024-09-03 PCVX Cowan Elvia SVP, Fin F - Tax $110.15 -1,145 11.6K -9% -$126.1K
D 2024-09-05 2024-09-03 PCVX Cowan Elvia SVP, Fin M - OptEx $0.00 -5,000 114.0K -4% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-09-03 M A 5,000 $25.92 17,723 D — —
2 Common Common Stock 2024-09-03 S D 5,000 $107.67 12,723 D — —
3 Common Common Stock 2024-09-03 F D 1,145 $110.15 11,578 D — — (F2) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units. No other shares of common stock subject to the restrictions on transfer set forth in a Lock-Up Agreement dated September 4, 2024 were sold by the Reporting Person.
4 Derivative Stock Option (right to buy) 2024-09-03 M D 5,000 $0.00 114,000 D $25.92 · — to 2032-08-08 5,000 Common Stock (F3) 1/4 of the shares subject to the option vested on July 1, 2023, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.